Domperidone Dosing for a 13.6 kg, 2-Year-Old Child
For a 13.6 kg, 2-year-old child with abdominal pain, administer domperidone at 0.25 mg/kg per dose (3.4 mg), which equals approximately 0.7 mL of the 5 mg/mL drops, given three times daily 15-30 minutes before meals.
Dosing Calculation and Rationale
The standard pediatric dose of domperidone is 0.25 mg/kg per dose, administered 3 times daily before meals 1. For this 13.6 kg child:
- Dose per administration: 0.25 mg/kg × 13.6 kg = 3.4 mg
- Volume per dose: 3.4 mg ÷ 5 mg/mL = 0.68 mL (round to 0.7 mL)
- Frequency: Three times daily, 15-30 minutes before meals
- Total daily dose: 10.2 mg/day (well within safe limits)
Evidence Supporting Use in Pediatric Abdominal Pain
Domperidone has demonstrated efficacy specifically for functional abdominal pain in children aged 5-12 years, with significant improvement in abdominal pain severity (54.1% reduction vs 24.7% placebo, P = 0.008) and patient-reported general improvement (74% vs 50% placebo, P = 0.013) at 8 weeks 1.
- At 6-month follow-up, 60% of children treated with domperidone achieved cure compared to 38% with placebo (P = 0.028) 1
- The medication acts as a prokinetic agent through dopamine-2 receptor antagonism, improving gastric motility without crossing the blood-brain barrier significantly 2
- No intervention-related adverse effects were reported in the pediatric trial 1
Administration Guidelines
Timing is critical for optimal efficacy:
- Administer 15-30 minutes before each of the three main meals 1
- This pre-meal timing allows the prokinetic effect to enhance gastric emptying when food is consumed
- The medication improves symptoms through effects on the chemoreceptor trigger zone and motor function of the stomach and small intestine 2
Safety Profile and Monitoring
Domperidone has an excellent safety profile in children due to minimal blood-brain barrier penetration, unlike metoclopramide which causes neurological side effects 2. In the largest pediatric study:
- No adverse effects were reported in children with functional abdominal pain 1
- In adult studies, side effects occurred in approximately 12% of patients, most commonly headache, tachycardia/palpitations, and diarrhea 3
- Only 12% of adults discontinued treatment due to side effects 3
Monitor for:
- Symptom improvement within 3 days of starting treatment (when improvement typically begins) 4
- Rare cardiac effects (palpitations), though uncommon in pediatric populations
- Headache or gastrointestinal symptoms
Clinical Pitfalls to Avoid
Common dosing errors:
- Do not confuse the concentration: 5 mg/mL means each mL contains 5 mg, not 5 mg per 5 mL
- Do not use "every 8 hours" dosing—domperidone for gastroparesis/abdominal pain is dosed TID (three times daily) before meals, not on a strict 8-hour schedule 1, 3
- Ensure pre-meal administration timing; giving with or after meals reduces efficacy
Age consideration: While the primary pediatric study enrolled children 5-12 years old 1, domperidone is used in younger children at weight-based dosing of 0.25 mg/kg per dose. At 2 years old, this child falls within the acceptable age range for off-label use with appropriate monitoring.
Expected Outcomes
Symptom improvement timeline 4:
- Initial improvement typically occurs by day 3 of treatment
- Significant reduction in abdominal pain severity by week 8
- Sustained benefit through 6 months of follow-up in pediatric studies 1
Primary symptoms that improve include postprandial fullness, nausea, upper abdominal pain, and overall gastroparesis symptoms 4, 1, 3.